Study | Newly significant | Newly insignificant |
---|
Trisomy 21 | 47 | 29 |
Trisomy 18 | 37 | 16 |
Maternal/fetal blood* | 22 | 6 |
BPD | 50 | 27 |
Leukemia | 108 | 49 |
- Total number of gene sets (either “unique” or “common”) showing enrichment (GSEA p < 0.05) with only the DFLAT collection (“Newly significant”) or the GOA collection (“Newly insignificant”).
- *Because of the design of this study, these numbers report the significant changes only in the meaningful direction: gene sets that might characterize fetal gene expression in maternal blood. Changes in the other direction likely characterize maternal response to Cesarean delivery.